日本糖尿病性腎症研究会 - 腎症最新ニュース -

The Shiga International Symposium on Diabetic Nephropathy
- Developing Current Concepts into Future Therapeutic Strategies -

Date : March 20-21, 2008
Venue : Biwako Hotel Room“RURI”on the 3rd Floor
　　　　 Hama-machi 2-40, Otsu, Shiga, 520-0041 Japan
　　　　 Tel 077-524-7111 (Overseas +81-77-524-7111)
Organizer : Shiga University of Medical Science
President : Ryuichi Kikkawa, M.D., Ph.D.
　　　　　　　　President, Shiga University of Medical Science

Thursday, March 20, 2008

8:30〜 8:45〜10:45	Opening Remarks　　　　Atsunori Kashiwagi (Shiga, Japan) Session I. Current clinical aspect of diabetic nephropathy. 　　　　　Chairpersons: Nigishi Hotta (Aichi, Japan) 　　　　　Sho Isogai (Kanagawa, Japan) Paradigms and paradigm shift in diabetic and renal disease 　　　　　Carl Erik Mogensen (Aarhus, Denmark). Implications of the changing course of diabetic nephropathy in the Pima Indians 　　　　　Robert G. Nelson (Phoenix, USA) Diabetic nephropathy - What are the unmet needs? 　　　　　Juliana C. N. Chan (Hong Kong, China)
10:55〜12:35	Session II. New markers related to the progression of diabetic nephropathy. 　　　　　Chairpersons: Hunjoo Ha (Seoul, Korea) 　　　　　Kazuwa Nakao (Kyoto Japan) Pathogenetic approach for diabetic nephropathy 　　- How we can overcome the current clinical problems? 　　　　　Toshio Doi (Tokushima, Japan) Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine? 　　　　　Toshio Miyata (Kanagawa, Japan) New markers related to the progression of diabetic nephropathy 　　　　　George Jerums (Heidelberg, Australia)
13:35〜14:30 14:30〜15:30	Poster Preview Session Special Lecture 　　　　　Chairperson: Ryuichi Kikkawa (Shiga, Japan) “BioBank Japan” project toward the personalized medicine 　　　　　Yusuke Nakamura (Tokyo, Japan)
15:30〜16:50	Session III. Pathophysiology of diabetic nephropathy. 　　　　　Chairpersons: Kazo Kaizu (Kanagawa, Japan) 　　　　　Atunori Kashiwagi (Shiga, Japan) Different roles for TGF-_ and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy 　　　　　Fuad N. Ziyadeh (Beirut, Lebanon) Role of ROS in the pathogenesis of diabetic nephropathy 　　　　　Hi Bahl Lee (Seoul, Korea)
17:00〜18:50	Session IV. Factors associated with the progression and regression of diabetic nephropathy. 　　　　　Chairpersons : Takayoshi Toyota (Miyagi, Japan) 　　　　　Robert G Nelson (Phoenix, USA) Structural factors associated with progression and regression of diabetic nephropathy 　　　　　Michael Mauer (Minneapolis, USA) Early progressive renal function decline in patients with type 1 diabetes and microalbuminuria 　　　　　Andrzej S. Krolewski (Boston, USA) A clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus 　　　　　Shin-ichi Araki (Otsu, Japan)
20:00〜21:30	Poster Discussion

Friday, March 21, 2008

8:45〜10:15	Session V. Novel therapeutic targets in diabetic nephropathy. 　　　　　Chairpersons: George Jerums (Heidelberg, Australia) 　　　　　Shiro Maeda (Kanagawa, Japan) Role of TSC-mTOR pathway in podocyte injury 　　　　　Ken Inoki (Ann Arbor, USA) New therapy for diabetic nephropathy by a (pro)renin-receptor-blocking decoy peptide 　　　　　Atsuhiro Ichihara (Tokyo, Japan) Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy 　　　　　Takahiko Nakagawa (Gainesville, USA)
10:30〜11:50	Session VI. New concept in the treatment of diabetic nephropathy. 　　　　　Chairpersons: Andrzej S. Krolewski (Boston, USA) 　　　　　Naoko Tajima (Tokyo, Japan) Protein kinase C β inhibition: Early results of clinical studies in diabetic kidney disease 　　　　　Katherine R. Tuttle (Spokane, USA) New treatments for diabetic nephropathy : Focus on advanced glycation 　　　　　Mark E. Cooper (Melbourne, Australia)
11:50〜12:05	Closing Remarks　　　　Ryuichi Kikkawa (Shiga, Japan)